Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Dubé

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Cardiovascular Toxicology|October 8, 2004
Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agentsSudha S Shankar, Michael P Dubé
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2002
Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophySamir K Gupta, Michael P Dubé
Best Practice & Research. Clinical Endocrinology & Metabolism|June 14, 2011
Lipid metabolism in treated HIV InfectionMichael P Dubé, Joseph J Cadden
Cardiovascular Toxicology|January 4, 2008
Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjectsMichael P Dubé, Jude Christopher Gorski, Changyu Shen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2008
No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trialMichael P Dubé, Changyu Shen, Martha Greenwald, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 14, 2023
Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencingGina Faraci, Sung Yong Park, Michael P Dubé, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 18, 2005
The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trialSamir K Gupta, Robert A Parker, Gregory K Robbins, et al.
The Journal of Infectious Diseases|October 21, 2011
Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertensionSamir K Gupta, Changyu Shen, Kieren J Mather, et al.
Plos One|August 18, 2017
HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stressAndrew Dysangco, Ziyue Liu, James H Stein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 27, 2013
Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trialSamir K Gupta, Deming Mi, Sharon M Moe, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Cardiovascular Toxicology|October 8, 2004
Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agentsSudha S Shankar, Michael P Dubé
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2002
Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophySamir K Gupta, Michael P Dubé
Best Practice & Research. Clinical Endocrinology & Metabolism|June 14, 2011
Lipid metabolism in treated HIV InfectionMichael P Dubé, Joseph J Cadden
Cardiovascular Toxicology|January 4, 2008
Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjectsMichael P Dubé, Jude Christopher Gorski, Changyu Shen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2008
No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trialMichael P Dubé, Changyu Shen, Martha Greenwald, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 14, 2023
Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencingGina Faraci, Sung Yong Park, Michael P Dubé, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 18, 2005
The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trialSamir K Gupta, Robert A Parker, Gregory K Robbins, et al.
The Journal of Infectious Diseases|October 21, 2011
Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertensionSamir K Gupta, Changyu Shen, Kieren J Mather, et al.
Plos One|August 18, 2017
HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stressAndrew Dysangco, Ziyue Liu, James H Stein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 27, 2013
Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trialSamir K Gupta, Deming Mi, Sharon M Moe, et al.
Pageof 6